// App-Quantinova.ai

: Early-life respiratory bacterial infection-induced chronic lung disease is driven by a novel TLR2/IL-13/miR-21/PI3K-dependent, but MyD88-independent signalling pathway

Researchers

Presenter

  • Malcolm Ronald Starkey

Principal Investigators

  • Duc H Nguyen

  • Richard Y Kim

  • Prema M Nair

  • TattJhong Haw

  • Jay C Horvat

  • Dale I Godfreyrew N McKenzie

  • Philip M Hansbro

Medical Centers

  • Univ. of Newcastle, Australia

  • Univ. of Melbourne, Carlton, Australia

  • University of Cambridge, Cambridge, United Kingdom

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Signal Transducer And Activator Of Transcription 6

  • Toll-like receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved